Oruka Therapeutics Inc. – Filings and Transcripts

NASDAQ: ORKA
Share price (11/6/26): $102.86
Market cap (11/6/26): $6.810 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Klein Lawrence Otto

Klein Lawrence Otto

Goncalves Joana

Goncalves Joana

News Filter

Announces Positive Week 16 Results for ORKA-001 From the Ongoing EVERLAST-B Trial in Moderate-To-Severe Psoriasis

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Shareholder Vote Results

Other Events, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC